Cleared Traditional

K222304 - Sonata Transcervical Fibroid Ablation System 2.2 (FDA 510(k) Clearance)

Nov 2022
Decision
99d
Days
Class 2
Risk

K222304 is an FDA 510(k) clearance for the Sonata Transcervical Fibroid Ablation System 2.2. This device is classified as a Coagulator-cutter, Endoscopic, Unipolar (and Accessories) (Class II - Special Controls, product code KNF).

Submitted by Gynesonics, Inc. (Redwood City, US). The FDA issued a Cleared decision on November 8, 2022, 99 days after receiving the submission on August 1, 2022.

This device falls under the Obstetrics & Gynecology FDA review panel. Regulated under 21 CFR 884.4160.

Submission Details

510(k) Number K222304 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 01, 2022
Decision Date November 08, 2022
Days to Decision 99 days
Submission Type Traditional
Review Panel Obstetrics & Gynecology (OB)
Summary Summary PDF

Device Classification

Product Code KNF - Coagulator-cutter, Endoscopic, Unipolar (and Accessories)
Device Class Class II - Special Controls
CFR Regulation 21 CFR 884.4160